Showing 1,523 results

Filters Content type: News, Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Pharmaceutical industry

Massachusetts official challenges Gilead's hepatitis C drug prices

Editor's pick
Reuters
28 January 2016
Pharmaceutical industry

AHF Files Federal Lawsuit Against Gilead to Invalidate Patents on Key AIDS Drug

Editor's pick
AIDS Healthcare Foundation
27 January 2016
Access to healthcare

Big Pharma’s worst nightmare

Editor's pick
The Guardian
26 January 2016
Pharmaceutical industry

Solving Pharma's Shkreli Problem

Editor's pick
Forbes
20 January 2016
New & experimental hepatitis C treatment

The 2016 Hepatitis C Drug Approval Outlook

Editor's pick
Poz
18 January 2016
Types of HIV tests

A Bill Gates backed fund is investing in an Aussie HIV testing company

Editor's pick
Sydney Morning Herald
14 January 2016
New & experimental hepatitis C treatment

Mylan Launches Generic Harvoni® (Ledipasvir/Sofosbuvir) Under the Brand Name MyHep LVIR™ in India

Editor's pick
Mylan press release
8 January 2016
Pharmaceutical industry

Why Do HIV Drug Ads Include Disclaimers for Actors?

Editor's pick
Slate Magazine (blog)
8 January 2016
Hepatitis B

J&J signs deal with Chinese company for hepatitis B drug

Editor's pick
Reuters
8 January 2016
New & experimental HIV treatments

Janssen, ViiV Healthcare Formalize Injectable Rilpivirine + Cabotegravir Phase 3 as HIV Treatment

Editor's pick
Street Insider
8 January 2016
Pharmaceutical industry

Martin Shkreli’s Arrest Gives Drug Makers Cover

Editor's pick
New York Times
22 December 2015
Pharmaceutical industry

GSK adds Bristol-Myers pipeline drugs to challenge Gilead in HIV

Editor's pick
FiercePharma
21 December 2015
Hepatitis C treatment

Concern over hepatitis C drug costs only the beginning, health officials say

Editor's pick
The News Tribune
21 December 2015
Access to healthcare

South Africa: New agreement could help end ARV stock outs

Editor's pick
Health-e
21 December 2015
Pharmaceutical industry

Bristol-Myers Squibb to Sell its HIV R&D Portfolio to ViiV Healthcare

Editor's pick
Bristol-Myers Squibb press release
18 December 2015
Pharmaceutical industry

Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges

Editor's pick
Bloomberg
17 December 2015
Pharmaceutical industry

A New Look Behind the Pricing of a $1,000 Pill

Editor's pick
Open Society Foundations
8 December 2015
Pharmaceutical industry

Gilead Used `Revenue-Driven Pricing' on Hep C Drug, Senators Say

Editor's pick
Bloomberg
1 December 2015
Access to healthcare

Express Scripts backs Imprimis' $1 pill over $750 Daraprim

Editor's pick
Reuters
1 December 2015
Pharmaceutical industry

Martin Shkreli walks back on pledge to lower price of HIV drug Daraprim

Editor's pick
The Guardian
26 November 2015
Hepatitis C treatment

Pricing Pressures: How the Business of Medicine Affects the Price of Therapy

Editor's pick
Healio HCV Next
16 November 2015
Hepatitis C treatment

U.S. FDA approves new indications for Harvoni®, Gilead’s once-daily single tablet regimen for chronic hepatitis C

Editor's pick
Gilled press release
13 November 2015
Pharmaceutical industry

High Cost of HIV Meds, Other Drugs Should Be Top Presidential Concern, Most Americans Say

Editor's pick
The Body
11 November 2015
PrEP

'Significant Victory' as Gilead Expands Co-Pay Assistance for Truvada as PrEP

Editor's pick
Poz
6 November 2015